Related Experiment Videos
Expansive benign lesions: treatment by laser
1Department of Gynecology, Catholic University of Louvain, Cliniques Universitaires St Luc, Brussels, Belgium.
Summary
This study shows hysteroscopic myomectomy and endometrial ablation effectively treat meno-metrorrhagia in women over 40. Preoperative gonadotropin-releasing hormone (GnRH) agonist therapy enhances outcomes for these gynecological conditions.
Area of Science:
- Gynecology
- Minimally Invasive Surgery
- Reproductive Medicine
Background:
- Meno-metrorrhagia in women over 40 is often caused by submucous fibroids, polyps, and dysfunctional bleeding.
- Hysteroscopic techniques offer minimally invasive solutions for these uterine conditions.
Purpose of the Study:
- To evaluate the efficacy of hysteroscopic myomectomy and endometrial ablation for treating meno-metrorrhagia.
- To assess the benefits of preoperative gonadotropin-releasing hormone (GnRH) agonist therapy in conjunction with these procedures.
Main Methods:
- Hysteroscopic myomectomy and endometrial ablation were performed using the Nd-YAG laser.
- Patients received preoperative GnRH agonist therapy to prepare for the procedures.
- The study included a series of 746 patients.
Main Results:
- A total of 746 patients were treated: 366 underwent myomectomy and 380 underwent endometrial ablation.
- The Nd-YAG laser hysteroscopic approach was utilized for both procedures.
- Preoperative GnRH agonist therapy demonstrated advantages in managing meno-metrorrhagia.
Conclusions:
- Hysteroscopic myomectomy and endometrial ablation are effective treatments for meno-metrorrhagia in women over 40.
- The use of Nd-YAG laser technology facilitates these hysteroscopic interventions.
- GnRH agonist therapy is a beneficial adjunct for improving treatment outcomes.